NDB expands to 11 members, raises $16.1bn in 2024, says Rousseff    Egypt, Somalia leaders discuss strategic partnership, counterterrorism in New Alamein    Egypt, UNDP discuss expanded cooperation on medical waste management, human development    CIB finances Giza Pyramids Sound and Light Show redevelopment with EGP 963m loan    EGX closes mixed on July 7th    Gold retreats as investors await tariff clarity    Egypt, UNDP discuss future health projects – Cabinet    Egypt calls for stronger central bank cooperation, local currency use at BRICS summit    Egypt's PM, Uruguay's president discuss Gaza, trade at BRICS summit    Egypt's Talaat Moustafa Group H1 sales jump 59% to EGP 211bn    Egypt, Uruguay eager to expand trade across key sectors    Egypt accelerates coastal protection projects amid rising climate threats    Deadly Israeli airstrikes pound Gaza as Doha talks raise hopes for ceasefire    Egypt, Norway hold informal talks ahead of global plastic treaty negotiations    Greco-Roman tombs with hieroglyphic inscriptions discovered in Aswan    Global tour for Korean 'K-Comics' launches in Cairo with 'Hellbound' exhibition    Egypt teams up with private sector to boost university rankings    Egypt reveals heritage e-training portal    Three ancient rock-cut tombs discovered in Aswan    Egypt condemns deadly terrorist attack in Niger        Egypt's EHA, Schneider Electric sign MoU on sustainable infrastructure    Sisi launches new support initiative for families of war, terrorism victims    Egypt expands e-ticketing to 110 heritage sites, adds self-service kiosks at Saqqara    Egypt's EDA joins high-level Africa-Europe medicines regulatory talks    Egypt's Irrigation Minister urges scientific cooperation to tackle water scarcity    Palm Hills Squash Open debuts with 48 international stars, $250,000 prize pool    Egypt's Democratic Generation Party Evaluates 84 Candidates Ahead of Parliamentary Vote    On Sport to broadcast Pan Arab Golf Championship for Juniors and Ladies in Egypt    Golf Festival in Cairo to mark Arab Golf Federation's 50th anniversary    Germany among EU's priciest labour markets – official data    Cabinet approves establishment of national medical tourism council to boost healthcare sector    Egypt's PM follows up on Julius Nyerere dam project in Tanzania    Egypt's FM inspects Julius Nyerere Dam project in Tanzania    Paris Olympic gold '24 medals hit record value    A minute of silence for Egyptian sports    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Saudi Arabia to get AstraZeneca shots in about a week from India
Published in Ahram Online on 25 - 01 - 2021

The Serum Institute of India (SII) will supply Saudi Arabia with 3 million AstraZeneca COVID-19 vaccine doses priced at $5.25 each in about a week on behalf of the British drugmaker, its chief executive told Reuters on Monday.
SII has no immediate plans, however, to divert supplies to Europe, even though AstraZeneca has come under pressure from the EU to deliver more shots after announcing a big cut in shipments due to production problems at a Belgian factory.
SII, the world's biggest vaccine manufacturer, has partnered with AstraZeneca, the Gates Foundation and the Gavi vaccine alliance to make up to a billion doses for poorer countries.
The Indian company supplies doses on behalf of AstraZeneca but is also free to strike its own supply deals.
"We continue to support AstraZeneca wherever they need the support. We are happy to do so," Chief Executive Adar Poonawalla told Reuters in an interview.
"But we have not been asked to supply any more products for Europe because then that would mean supplies to Africa and India would suffer, and we certainly don't want that," he said. "Once I satisfy that I can look at other, richer nations. Six months to a year, that could change."
He said the doses destined for Saudi Arabia would be shipped in a week or 10 days. SII is also supplying South Africa with 1.5 million doses at the same price of $5.25 each on behalf of AstraZeneca.
"We have our hands full, in fact, with the volumes even we need to supply," Poonawalla said. "We have been on time and we are able to supply to all these nations."
The pricing of the deal between South Africa and AstraZeneca has sparked some controversy as it is higher than the $3 a dose that South Africa and other countries on the continent are due to pay for the vaccine under an African Union arrangement.
AstraZeneca has said it will not profit from the vaccine during the pandemic.
Brazil last week received 2 million doses of the vaccine from SII and Poonawalla said it also paid about $5 per dose.
Poonawalla said that SII would raise production of the AstraZeneca vaccine by 30% by the end of March from its current daily output of about 2.4 million doses, once the third and final facility making the shot comes online.
SII also plans to start stockpiling a vaccine candidate from US company Novavax Inc in a few months, despite a fire last week that killed five people and damaged one of its new plants in the western Indian city of Pune.
Poonawalla said SII had no intention of partnering with companies such as Pfizer Inc whose COVID-19 vaccine needs to be stored at about minus 70 Celsius (minus 94 Fahrenheit) as India currently lacks such facilities.
Pfizer, which developed the shot with Germany's BioNTech , told Reuters it would pursue its request for India to approve the vaccine if the government committed to buying shots.
Pfizer was the first drugmaker to seek emergency use authorisation for its vaccine in India in early December but it has yet to be approved.
India's drug regulator says Pfizer officials failed to attend subsequent meetings it had called. The US drugmaker says its officials had not been given enough notice.


Clic here to read the story from its source.